Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Li, Ruth ^a   Ackerman IV, William E ^a   Mihai, Cosmin ^c   Volakis, Leonithas I ^b   Ghadiali, Samir ^a,b   Kniss, Douglas A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Ohio State University   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MYOFERLIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; UPREGULATION;

CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL SHAPE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MUSCLE PROTEINS; NEOPLASM INVASIVENESS;

MAMMALIA;

EID: 84862996842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039766     Document Type: Article

References (54)

1. American Cancer Society (2009) Breast Cancer Facts & Figures 2009-2010.
2. Horner MRL, Krapcho M, Neyman N, Aminou R, Howlader N, et al. (2009) SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. National Cancer Institute Surveillance Epidemiology and End Results website. Available:http://seer.cancer.gov/csr/1975_2006/. Accessed 2012 Jan 12.
3. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
4. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
5. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
6. Chaffer CL, Weinberg RA, (2011) A perspective on cancer cell metastasis. Science 331: 1559-1564.
7. Sabeh F, Shimizu-Hirota R, Weiss SJ, (2009) Protease-dependent versus-independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 185: 11-19.
8. Yilmaz M, Christofori G, (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8: 629-642.
9. Fletcher SJ, Rappoport JZ, (2009) The role of vesicle trafficking in epithelial cell motility. Biochem Soc Trans 37: 1072-1076.
10. Caswell P, Norman J, (2008) Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol 18: 257-263.
11. Mills GB, Jurisica I, Yarden Y, Norman JC, (2009) Genomic amplicons target vesicle recycling in breast cancer. J Clin Invest 119: 2123-2127.
12. Frittoli E, Palamidessi A, Disanza A, Scita G, (2011) Secretory and endo/exocytic trafficking in invadopodia formation: the MT1-MMP paradigm. Eur J Cell Biol 90: 108-114.
13. Caldieri G, Buccione R, (2010) Aiming for invadopodia: organizing polarized delivery at sites of invasion. Trends Cell Biol 20: 64-70.
14. Lek A, Lek M, North KN, Cooper ST, (2010) Phylogenetic analysis of ferlin genes reveals ancient eukaryotic origins. BMC Evol Biol 10: 231.
15. Washington NL, Ward S, (2006) FER-1 regulates Ca2+-mediated membrane fusion during C. elegans spermatogenesis. J Cell Sci 119: 2552-2562.
16. Liu J, Aoki M, Illa I, Wu C, Fardeau M, et al. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20: 31-36.
17. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, et al. (2003) Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 278: 50466-50473.
18. Bansal D, Campbell KP, (2004) Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 14: 206-213.
19. Han R, Campbell KP, (2007) Dysferlin and muscle membrane repair. Curr Opin Cell Biol 19: 409-416.
20. Yasunaga S, Grati M, Chardenoux S, Smith TN, Friedman TB, et al. (2000) OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9. Am J Hum Genet 67: 591-600.
21. Roux I, Safieddine S, Nouvian R, Grati M, Simmler MC, et al. (2006) Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 127: 277-289.
22. Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, et al. (2005) Normal myoblast fusion requires myoferlin. Development 132: 5565-5575.
23. Bernatchez PN, Sharma A, Kodaman P, Sessa WC, (2009) Myoferlin is critical for endocytosis in endothelial cells. Am J Physiol Cell Physiol 297: C484-C492.
24. Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, et al. (2007) Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function. J Biol Chem 282: 30745-30753.
25. Yu C, Sharma A, Trane A, Utokaparch S, Leung C, et al. (2011) Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo. Vascul Pharmacol.
26. Demonbreun AR, Posey AD, Heretis K, Swaggart KA, Earley JU, et al. (2010) Myoferlin is required for insulin-like growth factor response and muscle growth. FASEB J 24: 1284-1295.
27. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
28. Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, et al. (2004) Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 64: 844-856.
29. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, et al. (2003) Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 278: 6482-6489.
30. Eisenberg MC, Kim Y, Li R, Ackerman WE, Kniss DA, et al. (2011) Mechanistic modeling of the effects of myoferlin on tumor cell invasion. Proc Natl Acad Sci U S A 108: 20078-20083.
31. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, et al. (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213: 374-383.
32. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086.
33. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, et al. (1992) Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534-544.
34. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527.
35. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, et al. (2009) ArrayExpress update-from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 37: D868-D872.
36. Cheng AS, Culhane AC, Chan MW, Venkataramu CR, Ehrich M, et al. (2008) Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res 68: 1786-1796.
37. Cipta S, Patel HH, (2009) Molecular bandages: inside-out, outside-in repair of cellular membranes. Focus on "Myoferlin is critical for endocytosis in endothelial cells". Am J Physiol Cell Physiol 297: C481-C483.
38. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N, (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2: 252-257.
39. Pardo A, Selman M, (2005) MMP-1: the elder of the family. Int J Biochem Cell Biol 37: 283-288.
40. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, et al. (1992) Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 202: 1-8.
41. Jackson AL, Linsley PS, (2010) Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9: 57-67.
42. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
43. Griffiths-Jones S, (2006) miRBase: the microRNA sequence database. Methods Mol Biol 342: 129-138.
44. Argon Y, Ward S, (1980) Caenorhabditis elegans fertilization-defective mutants with abnormal sperm. Genetics 96: 413-433.
45. Achanzar WE, Ward S, (1997) A nematode gene required for sperm vesicle fusion. J Cell Sci 110 (Pt 9): 1073-1081.
46. Gupta GP, Massague J, (2006) Cancer metastasis: building a framework. Cell 127: 679-695.
47. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
48. Friedl P, Wolf K, (2009) Proteolytic interstitial cell migration: a five-step process. Cancer Metastasis Rev 28: 129-135.
49. Rowe RG, Weiss SJ, (2008) Breaching the basement membrane: who, when and how? Trends Cell Biol 18: 560-574.
50. Rowe RG, Weiss SJ, (2009) Navigating ECM barriers at the invasive front: the cancer cell-stroma interface. Annu Rev Cell Dev Biol 25: 567-595.
51. Demonbreun AR, Fahrenbach JP, Deveaux K, Earley JU, Pytel P, et al. (2011) Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet 20: 779-789.
52. Sharma A, Yu C, Leung C, Trane A, Lau M, et al. (2010) A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis. Arterioscler Thromb Vasc Biol 30: 2196-2204.
53. Debnath J, Muthuswamy SK, Brugge JS, (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
54. Lynch CC, Matrisian LM, (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation 70: 561-573.